Topoisomerase
Topoisomerase are enzymes that regulate the overwinding or underwinding of DNA.
Products for Topoisomerase
- Cat.No. Product Name Information
-
GC38194
(±)-10-Hydroxycamptothecin
(±)-10-Hydroxycamptothecin is an indole alkaloid that inhibits the activity of topoisomerase I and has a broad spectrum of anticancer activity.
-
GC73670
(αR)-Cyclopropaneacetamide-Exatecan
(αR)-Cyclopropaneacetamide-Exatecan (compound 2-A), an Exenotecan derivative, is a cytotoxic agent.
-
GC73057
(1R,9R)-Exatecan mesylate
(1R,9R)-DX8951f
(1R,9R)-Exatecan mesylate((1R,9R)-DX8951f) is an isomer of Exatecan mesylate. -
GC73056
(1S,9R)-Exatecan mesylate
(1S,9R)-DX8951f
(1S,9R)-Exatecan mesylate ((1S,9R)-DX8951f) is an isomer of Exatecan mesylate. -
GC74127
(R)-Exatecan Intermediate 1
(R)-Exatecan Intermediate 1 is an isomer of Exatecan Intermediate 1.
-
GC10098
(S)-10-Hydroxycamptothecin
ChEMBL 273862, NSC 107124
inhibitor of topoisomerase I -
GC17271
4'-Demethylepipodophyllotoxin
(-)-4′-Demethylepipodophyllotoxin
An inhibitor of tubulin polymerization -
GC41643
9(Z),11(E),13(E)-Octadecatrienoic Acid
αEleostearic Acid, αESA, LAF 237
9(Z),11(E),13(E)-Octadecatrienoic Acid (α-ESA) is a conjugated polyunsaturated fatty acid commonly found in plant seed oil. -
GC11903
9-amino Camptothecin
NSC 603071
9-amino Camptothecin (9-amino-20(S)-camptothecin) is a topoisomerase I inhibitor with potent anticancer activity. -
GC45367
9-Hydroxyellipticine (hydrochloride)
9-OH-Ellipticine, NSC 210717
-
GN10035
9-Methoxycamptothecin
-
GC74178
Ac-Exatecan
Ac-Exatecan is acetylated Exatecan.
-
GC35238
Aclacinomycin A hydrochloride
Aclacinomycin A hydrochloride (Aclarubicin hydrochloride), a fluorescent molecule and the first described non-peptidic inhibitor showing discrete specificity for the CTRL (chymotrypsin-like) activity of the 20S proteasome. Aclacinomycin A hydrochloride is also a dual inhibitor of topoisomerase I and II. An effective anthracycline chemotherapeutic agent for hematologic cancers and solid tumors.
-
GC49804
Acridine
2,3,5,6-Dibenzopyridine, 10-Azaanthracene, Dibenzopyridine, NSC 3408
An azaarene -
GC14858
Aldoxorubicin
INNO-206;Doxorubicin-EMCH;INNO 206
An albumin-binding prodrug of doxorubicin -
GC10779
Alternariol
AOH,NSC 638263
A mycotoxin with antifungal and phytotoxic activity
-
GC42783
Ametantrone
NSC 196473, NSC 290813
Ametantrone (NSC 196473) is an antitumor agent that intercalates into DNA and induces topoisomerase II (TOP2)-mediated DNA break. -
GC11019
Amonafide
AS1413, Benzisoquinolinedione, Nafidimide, NCI 308847, NSC 308847
DNA intercalator,Topo II inhibitor -
GC15644
Amrubicin
SM-5887
A synthetic anthracycline antibiotic. It inhibits DNA topoisomerase II. Antineoplastic. -
GC12326
Amsacrine
Topoisomerase 2 inhibitor
-
GC11747
Amsacrine hydrochloride
AMSA, m-AMSA, NSC 141549
Topoisomerase 2 inhibitor -
GC62425
ARN-21934
ARN-21934 is a potent, highly selective, blood-brain barrier (BBB) penetrant inhibitor for human topoisomerase II α over β. ARN-21934 inhibits DNA relaxation with an IC50 of 2 μM as compared to the anticancer agent Etoposide (IC50=120 μM). ARN-21934 exhibits a favorable in vivo pharmacokinetic profile and is a promising lead compound for anticancer research.
-
GC46880
ARN24139
A topoisomerase II poison
-
GC39699
Aurintricarboxylic acid
Aurintricarboxylic acid is a nanomolar-potency, allosteric antagonist with selectivity towards αβ-methylene-ATP-sensitive P2X1Rs and P2X3Rs, with IC50s of 8.6 nM and 72.9 nM for rP2X1R and rP2X3R, respectively.
-
GC33240
Banoxantrone D12 (AQ4N D12)
AQ4N D12
Banoxantrone D12 (AQ4N D12) is the deuterium labeled banoxantrone. Banoxantrone is a novel bioreductive agent that can be reduced to a stable, DNA-affinic compound AQ4, which is a potent topoisomerase II inhibitor. -
GC34169
Banoxantrone D12 dihydrochloride (AQ4N D12 dihydrochloride)
AQ4N-d12 dihydrochloride
Banoxantrone-d12 (AQ4N-d12) dihydrochloride is the deuterium labeled Banoxantrone dihydrochloride. Banoxantrone is a novel bioreductive agent that can be reduced to a stable, DNA-affinic compound AQ4, which is a potent topoisomerase II inhibitor. -
GC34085
Banoxantrone dihydrochloride (AQ4N dihydrochloride)
AQ4N dihydrochloride
Banoxantrone dihydrochloride (AQ4N dihydrochloride) is an oxygen-depleted activated topoisomerase II inhibitor, AQ4N binds to DNA in a non-covalent manner and promotes antitumor activity of hypoxic and hypoxic tumor cells. -
GC42912
Becatecarin
BMS 181176, BMY 27557, NSC 655649, XL 119
Becatecarin is a water-soluble, diethylaminoethyl analog of the antineoplastic antibiotic rebeccamycin. -
GC33066
Belotecan hydrochloride (CKD-602)
7-2-(N-isopropylamino)ethyl-(20S)-Camptothecin, CKD602, (S)-CKD602
Belotecan hydrochloride (CKD-602) (CKD-602 hydrochloride), a Topoisomerase I inhibitor, is a synthetic camptothecin derivative. -
GN10221
Berberine
Berberine (Natural Yellow 18) is an alkaloid isolated from the Chinese herbal medicine Huanglian, as an antibiotic. Berberine (Natural Yellow 18) induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase.
-
GC35497
Berberine chloride hydrate
Berberine chloride hydrate (Natural Yellow 18 chloride hydrate) is an alkaloid that acts as an antibiotic. Berberine chloride hydrate induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties.
-
GN10208
Berberine hydrochloride
BBR, Umbellatine, NSC 163088, NSC 646666
Berberine hydrochloride is a bioactive alkaloid of the isoquinoline class derived from the medicinal plant Coptis chinensis of the Ranunculaceae family, possessing a wide range of pharmacological functions with applications in cancer, inflammation, diabetes, depression, hypertension, and various infections. -
GN10523
Berberine Sulfate
-
GC10734
Beta-Lapachone
ARQ 501, NSC 26326, NSC 629749, SL 11001
Beta-Lapachone (ARQ-501;NSC-26326) is a naturally occurring O-naphthoquinone, acts as a topoisomerase I inhibitor, and induces apoptosis by inhibiting cell cycle progression. -
GC10480
Betulinic acid
Lupatic Acid, NSC 113090
Betulinic acid is a natural pentacyclic triterpenoid compound and an inhibitor of eukaryotic topoisomerase I with an IC50 value of 5 μM. -
GC19073
Bisantrene
Bisantrene is a highly effective antitumor drug, targets eukaryotic type II topoisomerases.
-
GC68772
Bisantrene dihydrochloride
CL-216942 dihydrochloride
Bisantrene dihydrochloride is an effective anticancer agent that exerts cytotoxicity by affecting DNA intercalation. Bisantrene dihydrochloride targets the topoisomerase II of eukaryotes. Bisantrene dihydrochloride is a substrate for MDR1.
-
GC73205
Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT
Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT (Formula V) is a agent-linker conjugate that composed of a potent topoisomerase I inhibitor and a linker to make antibody agent conjugate (ADC).
-
GC15439
Camptothecin
MAGCPT, NSC 94600
Camptothecin is a specific DNA topoisomerase I (Top1) inhibitor with an IC50 value of 679 nM. -
GC60669
Camptothecin-20(S)-O-propionate
Camptothecin-20-O-propionate
Camptothecin-20(S)-O-propionate (CZ48), the C20-propionate ester of CPT, is a highly effective anticancer agent. Camptothecin-20(S)-O-propionate (CZ48) is a topoisomerase-Ι inhibitor. -
GC46113
CAY10744
A topoisomerase II-α poison
-
GC73843
CB07-Exatecan
CB07-Exatecan is an ADC drug-Linker conjugate that can be used for the synthesis of ADCs.
-
GC60692
CH-0793076 TFA
TP3076 TFA
CH-0793076 (TP3076) TFA, a hexacyclic camptothecin analog, is active drug and major metabolite of TP300. CH-0793076 TFA inhibits DNA topoisomerase I with an IC50 of 2.3 μM. CH-0793076 TFA is efficacious against cells expressing BCRP (breast cancer resistance protein). -
GC18536
Chartreusin
Antibiotic X 465A, Lambdamycin, NSC 5159
Chartreusin is an antibiotic originally isolated from S. -
GC72859
Chimmitecan
(S)-9-Allyl-10-Hydroxycamptothecin
Chimmitecan ((S)-9-Allyl-10-droxycamptothecin), a novel 9-small-alkyl-substituted lipophilic Camptothecin , is a potent inhibitor of topoisomerase I. -
GC60107
Chloroquinoxaline sulfonamide
Chloroquinoxaline sulfonamide (Chloroquinoxaline), a structural analogue of sulfaquinoxaline, is a topoisomerase II alpha/beta poison.
-
GC50105
CKD 602
Topoisomerase I inhibitor
-
GC47098
CL2-SN-38 (dichloroacetic acid salt)
An antibody-drug conjugate containing SN-38
-
GC60714
CL2A-SN-38
An antibody-drug conjugate containing SN-38
-
GC61965
Coralyne chloride
Coralyne chloride is a protoberberine alkaloid with potent anti-cancer activities. Coralyne chloride acts as a potent topoisomerase I poison and induces Top I mediated DNA cleavage. Coralyne chloride can be used for preparing?coralyne derivatives?as DNA binding fluorescent probes.
-
GC73634
Cu(II)-Elesclomol
Cu(II)-Elesclomol is a Cu2+ complex of Elesclomol.
-
GC73746
Cyclooctyne-O-amido-PEG4-VC-PAB-Gly-Gly-NH-O-CO-Exatecan
Cyclooctyne-O-amido-PEG4-VC-PAB-Gly-Gly-NH-O-CO-Exatecan is a drug-linker conjugate for ADC (ADC Cytotoxin: Exatecan).
-
GC73669
Cyclopropaneacetamide-Exatecan
Cyclopropaneacetamide-Exatecan (Compound 2-A) is an ADC Cytotoxin and an Exatecan analogue.
-
GC73079
Datopotamab deruxtecan
DS-1062; Dato-DXd
Datopotamab deruxtecan (DS-1062; Dato-DXd) is a trophoblast cell surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC). -
GC11175
Daun02
-
GC12828
Daunorubicin
DNA topoisomerase II inhibitor
-
GC10354
Daunorubicin HCl
NDC 00824155, Ondena, RP 13057
Daunorubicin (Daunomycin) hydrochloride is a topoisomerase II inhibitor with potent anti-tumor activity. -
GC73899
DBCO-β-Glu-PEG12-Exatecan
DBCO-β-Glu-PEG12-Exatecan (Compound 107) is an inhibitor for topoisomerase I.
-
GC73419
Decyclohexanamine-Exatecan
Decyclohexanamine-Exatecan is a Camptothecin derivative, compound a, extracted from patent WO2020219287 A1.
-
GC17412
Deferasirox Fe3+ chelate
-
GC11619
Dexrazoxane HCl (ICRF-187, ADR-529)
Topoisomerase II inhibitor,intracellular ion chelator,cardioprotective agent
-
GC15250
DOXO-EMCH
INNO-206;Doxorubicin-EMCH;INNO 206
Prodrug of doxorubicin -
GC17567
Doxorubicin (Adriamycin) HCl
DOX
Doxorubicin (Hydroxydaunorubicin) hydrochloride, a cytotoxic anthracycline antibiotic, is an anti-cancer chemotherapy agent. -
GC15399
Dp44mT
iron chelator and anticancer agent
-
GC38774
DRF-1042
DRF-1042 is an orally active derivative of Camptothecin. DRF-1042 acts to inhibit DNA topoisomerase I. DRF-1042 shows good anticancer activity against a panel of human cancer cell lines including multi-drug resistance (MDR) phenotype.
-
GC32926
Dxd (Exatecan derivative)
DXd is a derivative of Exatecan (DX-8951).
-
GC62212
Dxd-D5
Exatecan-d5 derivative for ADC
Dxd-d5 (Exatecan-d5 derivative for ADC) is a deuterium labeled Dxd. Dxd is a potent DNA topoisomerase I inhibitor, with an IC50 of 0.31 μM, used as a conjugated drug of HER2-targeting ADC (DS-8201a) . -
GC33128
Edotecarin (J 107088)
J 107088; PF 804950
Edotecarin (J 107088) is a potent inhibitor of topoisomerase I that can induces single-strand DNA cleavage, with IC50 of 50 nM. -
GC18620
EIDD-1931
β-D-N4-Hydroxycytidine, N4-Hydroxycytidine
A ribonucleoside analog with antiviral activity
-
GC15548
Ellagic acid
Gallogen, Lagistase, TBBD
Casein kinase 2 (CK2) inhibitor -
GC15305
Ellipticine
DNA topoisomerase II inhibitor
-
GC35973
Ellipticine hydrochloride
Ellipticine (NSC 71795) hydrochloride is a potent antineoplastic agent; inhibits DNA topoisomerase II activities.
-
GC35997
Epirubicin
Epirubicin (4'-Epidoxorubicin), a semisynthetic L-arabino derivative of doxorubicin, has an antineoplastic agent by inhibiting Topoisomerase. Epirubicin inhibits DNA and RNA synthesis. Epirubicin is a Forkhead box protein p3 (Foxp3) inhibitor and inhibits regulatory T cell activity.
-
GC10686
Epirubicin HCl
4’Epidoxorubicin
Epirubicin HCl (4'-Epidoxorubicin hydrochloride), a semisynthetic L-arabino derivative of doxorubicin, has an antineoplastic agent by inhibiting Topoisomerase. Epirubicin HCl inhibits DNA and RNA synthesis. Epirubicin HCl is a Forkhead box protein p3 (Foxp3) inhibitor and inhibits regulatory T cell activity. -
GC15617
Etoposide
VP-16; VP-16-213
Etoposide (VP-16) is a nonspecific inhibitor of topoisomerase II with an IC50 value of 59.2μM. -
GC60826
Etoposide phosphate
Etoposide phosphate (BMY-40481) is a potent anti-cancer chemotherapy agent and a selective topoisomerase II inhibitor?to prevent re-ligation of DNA strands.
-
GC33108
Exatecan (DX-8951)
Exatecan (DX-8951) is a nonprodrug camptothecin (CPT) derivative, exhibits significant topoisomerase I inhibition.
-
GC74150
Exatecan analog 36
Exatecan analog 36 is a analog of Exatecan.
-
GC62184
Exatecan D5 mesylate
DX8951f-d5; Exatecan-d5 mesylate; Deuterated labeled Exatecan mesylate
-
GC74652
Exatecan Intermediate 2 hydrochloride
Exatecan Intermediate 2 drochloride (compound B) is an intermediate of Exatecan (DX-8951, ).
-
GC74653
Exatecan Intermediate 4
Exatecan Intermediate 4 (compound B) is an intermediate of Exatecan (DX-8951, ).
-
GC74654
Exatecan Intermediate 4 dihydrochloride
Exatecan Intermediate 4 didrochloride is an intermediate of Exatecan (DX-8951, ).
-
GC74132
Exatecan Intermediate 5
Exatecan Intermediate 5 is the intermediate of Exatecan And Exatecan (DX-8951) is a DNA topoisomerase I inhibitor with an IC50 value of 2.2 μM (0.975 μg/mL) that can be used in cancer research.
-
GC74134
Exatecan Intermediate 6
Exatecan Intermediate 6 is the intermediate of Exatecan And Exatecan (DX-8951) is a DNA topoisomerase I inhibitor with an IC50 value of 2.2 μM (0.975 μg/mL) that can be used in cancer research.
-
GC74135
Exatecan Intermediate 7
Exatecan Intermediate 7 is the intermediate of Exatecan And Exatecan (DX-8951) is a DNA topoisomerase I inhibitor with an IC50 value of 2.2 μM (0.975 μg/mL) that can be used in cancer research.
-
GC19148
Exatecan Mesylate
DX 8951f
Exatecan Mesylate is a water soluble topoisomerase I inhibitor, with an IC50 of 2.2 uM (0.975 ug/mL), and can be used in cancer research. -
GC73711
Exatecan-methylacetamide-OH
Exatecan-metlacetamide-OH (compound 6) is a Exatecan derivative with anticancer effects.
-
GC16455
Flumequine
(±)-Flumequine, R-802
DNA topoisomerase II inhibitor,synthetic chemotherapeutic antibiotic -
GC49134
Flumequine-13C3
(±)-Flumequine-13C3, R-802-13C3
An internal standard for the quantification of flumequine -
GC70215
Fmoc-leucine-15N
Fmoc-leucine-15N is a 15N-labeled and 13C-labled EIDD-1931.
-
GC14376
Gatifloxacin
AM1155, BMS 20658401, PD 135432
Fluoroquinolone antibiotic,inhibits bacterial TOPO II -
GC14102
Genistein
CI-75610, NSC 36586
Genistein is an isoflavone belonging to the flavonoid group of compounds and is found in a number of plants. -
GC15853
Genz-644282
Genz644282;Genz 644282
An inhibitor of topoisomerase I -
GC32088
Gepotidacin (GSK2140944)
GSK2140944
Gepotidacin (GSK2140944) (GSK2140944) is a novel triazaacenaphthylene bacterial type II topoisomerase inhibitor. -
GC73458
GGFG-amide-glycol-amide-Exatecan
GGFG-amide-glycol-amide-Exatecan (Intermediate 2) is an Exatecan derivative and can be used in the synthesis of antibody-drug conjugates (ADCs).
-
GC60873
Gimatecan
ST1481
Gimatecan (ST1481) is a potent topoisomerase I inhibitor. Gimatecan is an orally bioavailable camptothecin analogue with antitumor activity. -
GC73055
Gly-Gly-Phe-Gly-NH-O-CO-Exatecan hydrochloride
Gly-Gly-Phe-Gly-NH-O-CO-Exatecan, as a drug-linker conjugate composed of linker Gly-Gly-Phe-Gly-NH-O-CO and Exatecan, can be used to prepare antibody conjugate drugs.
-
GC73503
Gly-Mal-GGFG-Deruxtecan 2-hydroxypropanamide
Gly-Mal-GGFG-Deruxtecan 2-droxy propionamide is a camptothecin-deriver and can be used as a drug linker for ADC.
-
GC38511
Groenlandicine
Groenlandicine is a protoberberine alkaloid isolated from Coptidis Rhizoma.
-
GC14969
Idarubicin HCl
4Demethoxydaunorubicin, 4DMD, NSC 256439
Idarubicin HCl is an anthracycline antileukemic drug.